Literature DB >> 20697034

Prospects for minocycline neuroprotection.

Jennifer M Plane1, Yan Shen, David E Pleasure, Wenbin Deng.   

Abstract

Minocycline is a clinically available antibiotic and anti-inflammatory drug that also demonstrates neuroprotective properties in a variety of experimental models of neurological diseases. There have thus far been more than 300 publications on minocycline neuroprotection, including a growing number of human studies. Our objective is to critically review the biological basis and translational potential of this action of minocycline on the nervous system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697034      PMCID: PMC3127230          DOI: 10.1001/archneurol.2010.191

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  39 in total

1.  Minocycline for Huntington's disease: an open label study.

Authors:  Raphael M Bonelli; Clemens Heuberger; Franz Reisecker
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

2.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Y Du; Z Ma; S Lin; R C Dodel; F Gao; K R Bales; L C Triarhou; E Chernet; K W Perry; D L Nelson; S Luecke; L A Phebus; F P Bymaster; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

3.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

4.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.

Authors:  J Yrjänheikki; T Tikka; R Keinänen; G Goldsteins; P H Chan; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Minocycline treatment reduces white matter damage after excitotoxic striatal injury.

Authors:  Joanilson S Guimarães; Marco Aurelio M Freire; Rafael R Lima; Cristovam W Picanço-Diniz; Antonio Pereira; Walace Gomes-Leal
Journal:  Brain Res       Date:  2010-03-11       Impact factor: 3.252

6.  Minocycline enhances MPTP toxicity to dopaminergic neurons.

Authors:  Lichuan Yang; Shuei Sugama; Jason W Chirichigno; Jason Gregorio; Stefan Lorenzl; Dong H Shin; Susan E Browne; Yoshinori Shimizu; Tong H Joh; M Flint Beal; David S Albers
Journal:  J Neurosci Res       Date:  2003-10-15       Impact factor: 4.164

7.  Minocycline in Huntington's disease: a pilot study.

Authors:  Madhavi Thomas; Tetsuo Ashizawa; Joseph Jankovic
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

8.  Minocycline and doxycycline are not beneficial in a model of Huntington's disease.

Authors:  Donna L Smith; Benjamin Woodman; Amarbirpal Mahal; Kirupa Sathasivam; Shabnam Ghazi-Noori; Philip A S Lowden; Gillian P Bates; Emma Hockly
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

9.  Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.

Authors:  Elsa Diguet; Pierre-Olivier Fernagut; Xing Wei; Yansheng Du; Richard Rouland; Christian Gross; Erwan Bezard; François Tison
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

10.  Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model.

Authors:  Masahiro Tsuji; Mary Ann Wilson; Mary S Lange; Michael V Johnston
Journal:  Exp Neurol       Date:  2004-09       Impact factor: 5.330

View more
  98 in total

Review 1.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.

Authors:  Marco Sisignano; Ralf Baron; Klaus Scholich; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2014-11-04       Impact factor: 42.937

Review 2.  Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening.

Authors:  Sareh Pandamooz; Mohammad Nabiuni; Jaleel Miyan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

Review 3.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

Authors:  Gislaine Zilli Réus; Airam Barbosa de Moura; Laura Araújo Borba; Helena Mendes Abelaira; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2019-05-21

4.  Minocycline attenuates microglial response and reduces neuronal death after cardiac arrest and cardiopulmonary resuscitation in mice.

Authors:  Qian-Yan Wang; Peng Sun; Qing Zhang; Shang-Long Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

5.  Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2.

Authors:  Jun Tang; Qianwei Chen; Jing Guo; Liming Yang; Yihao Tao; Lin Li; Hongping Miao; Hua Feng; Zhi Chen; Gang Zhu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

6.  Comparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.

Authors:  Cole Vonder Haar; Gail D Anderson; Brandy E Elmore; Lynn H Moore; Amanda M Wright; Eric D Kantor; Fred M Farin; Theo K Bammler; James W MacDonald; Michael R Hoane
Journal:  J Neurotrauma       Date:  2014-01-20       Impact factor: 5.269

Review 7.  The role of neuroimmune signaling in alcoholism.

Authors:  Fulton T Crews; Colleen J Lawrimore; T Jordan Walter; Leon G Coleman
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

8.  Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.

Authors:  Xiang Fan; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2013-02-19       Impact factor: 7.914

9.  Antioxidant-Rich Fraction of Urtica dioica Mediated Rescue of Striatal Mito-Oxidative Damage in MPTP-Induced Behavioral, Cellular, and Neurochemical Alterations in Rats.

Authors:  Rohit Bisht; Bhuwan Chandra Joshi; Ajudhiya Nath Kalia; Atish Prakash
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

10.  Central Renin-Angiotensin System Activation and Inflammation Induced by High-Fat Diet Sensitize Angiotensin II-Elicited Hypertension.

Authors:  Baojian Xue; Robert L Thunhorst; Yang Yu; Fang Guo; Terry G Beltz; Robert B Felder; Alan Kim Johnson
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.